ADMIRUS has considerable global expertise in navigating both pre-clinical and clinical development and understand the requirements for entry-into-man studies, single and escalating dose Phase 1 studies and more advanced phase II/III efficacy/safety studies. Navigating the regulatory terrain is a cor...See more
Headquarters:
Australia
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2022 (3 years)
Address:
SYDNEY, AU
LOW
spending power
